There are many challenges facing the biotech industry today, such as quality assurance, counterfeiting and research intransparency. GENEXI is determined to deliver a holistic solution in the form of a transparent and comprehensive blockchain-based ecosystem on to the market.
Within GENEXI Ecosystem biotech start-ups and projects will be able to find financial and advisory support to establish and scale-up their production. Upon entering the GENEXI Platform, distributors will be able to provide their services and build networks with vendors, while regular customers will gain an access to complete immutable data about the products. At the same time, third-party service providers will be able to present their support to other participants of the community. GENEXI plans to integrate its unique blockchain solution throughout the entire supply chain management process in order to fight drug counterfeit, fraud and quality manipulation and ensure full transparency at every level.
All ratings published on ICObench serve informational purposes only. ICObench does not provide investment forecast, recommendations or any consulting for that matter. Thus, neither ICObench, nor the experts can be hold responsible for the visitors’ investment decisions. Read more
Fundraising, China scaling, Project promotion, Government and Investor relation Rated on May 19, 2018
5
5
4
12%
The project intend to build transparency ecosystem for biotech and encourage the participation by using token as a media. It's a good direction and I looking forward to see it works.
However, from my many years experience of doing business with biotech, the player in biotech industry is usually very conservation and self-protected.
So, I think the challenge is not technology but how to promote and convincing all player. The core team is strong, but I will recommend invite more channel and sales partner to speed up market adaption.
Blockchain Enthusiast Rated on Jul 4, 2018 Modified on Jul 4, 2018
5
4
5
12%
The biotech industry has a great perspective using blockchain. This team is reinforced and quite numerous. This is a project with a good potential if well implemented. The WP still should be a bit improved as comes to numbers.
PhD | Entrepreneur | CEO | ICO Advisor | Crypto enthusiast | Blockchain expert | Public speaker | Mentor Rated on May 27, 2018
5
5
4
10%
UPD: Good and big team.
Great vision. And biotech is huge market.
MVP - will soon!
KYC - passed it's good
Vision is good
Need more strong marketing and PR
Very interesting product, although this is a very hard ecosystem to break in, as biotech breakthroughs can be very expensive to get. Great team and advisory board. Good luck team!
Co-Founder and CFO at CryptoDiffer | Investor| Marketing Specialist| Senior Analyst at Venture Fund Rated on May 21, 2018
5
5
5
8%
Nowadays biotech industry is very promising and implementation blockchain technology in it could provide a great competitive advantage to the project.
GENEXI wants to create not just some local solution but a complex product which will help to solve the problem of the supply chain, drug counterfeit, fraud and quality manipulation.
They have a solid and experienced team in the business sphere. Their MVP will be launched in Q3 this year, keep waiting.
In my opinion:
- Good team
- Nice vision
- The fact that the company is registered in Switzerland is a big plus for investors
- The market has high CAGR
Experts are independently and voluntarily contributing to the community. If no expert has rated the ICO, only ICO analyzer's results are used. Always research before investing as these ratings should not be taken as an investing guide of any kind.
Ratings and ICO analyzer results are being updated (re-calculated) every few hours.